CIA
LH icon

Concurrent Investment Advisors’s Labcorp LH Stock Holding History

Concurrent Investment Advisors’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Buy
5,369
+2,103
+64% +$553K 0.01% 817
2026
Q1 		$872K Sell
3,266
-30
-0.9% -$8.12K 0.01% 932
2025
Q4 		$827K Buy
3,296
+552
+20% +$147K 0.01% 921
2025
Q3 		$788K Buy
2,744
+235
+9% +$63K 0.01% 738
2025
Q2 		$659K Buy
2,509
+646
+35% +$157K 0.01% 749
2025
Q1 		$434K Buy
+1,863
New +$452K 0.01% 787

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Concurrent Investment Advisors's LH Position: Q2 2026 in Review

Concurrent Investment Advisors increased its Labcorp (LH) stake by 64% in Q2 2026, buying an estimated $553K and bringing the position to 5,369 shares worth $1.5M. The position accounts for 0.01% of the portfolio, ranked #817.

Concurrent Investment Advisors first reported a position in LH in Q1 2025 and has held it in 6 quarters since. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Concurrent Investment Advisors held 5,369 shares of Labcorp worth $1.5M as of Q2 2026.
  • Concurrent Investment Advisors bought 2,103 Labcorp shares in Q2 2026, an estimated $553K.
  • Labcorp made up 0.01% of Concurrent Investment Advisors's portfolio in Q2 2026, its #817 holding.
  • Concurrent Investment Advisors first reported a position in Labcorp in Q1 2025 and has held it in 6 quarters since.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.